40
Participants
Start Date
February 19, 2020
Primary Completion Date
August 30, 2026
Study Completion Date
December 31, 2026
Cladribine
All study participants will receive treatment with cladribine 10 mg tablets at the recommended cumulative dose of 3.5 mg/kg, divided into 2 yearly treatment courses (1.75 mg/kg per treatment course). This regimen corresponds to the recommended dosage as per the USPI
College Park Family Care Center Physicians Group, Overland Park
UT Southwestern Medical center, Dallas
Collaborators (1)
EMD Serono
INDUSTRY
University of Texas Southwestern Medical Center
OTHER